This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

A Prospective Cooperative Study

JAMA. 1972;220(5):692-701.

Abstract
Transfusion of 4,984 cardiovascular surgery patients with an average of 7.7 units of blood at 14 university medical centers resulted in symptomatic hepatitis in 2.8% and death in 0.1%. Among additional patients receiving fibrinogen and blood, the hepatitis incidence and mortality were 19% and 4%, respectively. These figures do not include 0.1% incidence of hepatitis within 15 days of receiving halogenated anesthetics, and 0.1% incidence of "postperfusion" syndrome. The risk of typical symptomatic posttransfusion hepatitis among the 14 centers varied, in order of correlation, with (1) the incidence of hepatitis type B antigen in donor blood, (2) the proportion of commercial donors, and (3) transfusion volume, and ranged from 0 to 8.6 per 100 patients, or 0 to 1.56/100 units of blood. Hepatitis was not prevented by intramuscular injections of immune serum globulin (-globulin) containing conventionally low amounts of hepatitis-B antibody.

Footnotes
From (Coordinating Center) the Biologic Laboratories, State Laboratory Institute, and the Medical Service, Lemuel Shattuck Hospital, Massachusetts Department of Public Health, and the departments of medicine and preventive medicine, Tufts University School of Medicine, Boston.

Reprint requests to 375 South St, Boston 02130 (Dr. Grady).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Blood transfusion: the silent epidemic
Spiess
Ann. Thorac. Surg. 2001;72:S1832-1837.
ABSTRACT | FULL TEXT  

The Use of Fibrin Tissue Adhesive to Reduce Blood Loss and the Need for Blood Transfusion After Total Knee Arthroplasty. A Prospective, Randomized, Multicenter Study
LEVY et al.
JBJS 1999;81:1580-8.
ABSTRACT | FULL TEXT  

Decrease in Reported Posttransfusion Hepatitis: Contributions of Donor Screening for Alanine Aminotransferase and Antibodies to Hepatitis B Core Antigen and Changes in the General Population
Chambers and Popovsky
Arch Intern Med 1991;151:2445-2448.
ABSTRACT  

Blood saving in cardiac surgery: simple approach and tendencies
Tixier et al.
Perfusion 1991;6:265-273.
 

Post-transfusion Hepatitis: Current Perspectives
AACH and KAHN
ANN INTERN MED 1980;92:539-546.
ABSTRACT  

Do Volunteer Donors Decrease Posttransfusion Hepatitis? Study in a Military Donor Population
Holley et al.
JAMA 1975;234:1051-1052.
ABSTRACT  

Prevention of Nosocomial Viral Hepatitis, Type B (Hepatitis B)
SNYDMAN et al.
ANN INTERN MED 1975;83:838-845.
ABSTRACT  

Hepatitis B in Plasma Fractionation Workers: A Seroepidemiologic Study
Taylor et al.
JAMA 1974;230:850-853.
ABSTRACT  

Parenterally Transmitted Hepatitis A Associated with Platelet Transfusions: Epidemiologic Study of an Outbreak in a Marrow Transplantation Center
MEYERS et al.
ANN INTERN MED 1974;81:145-151.
ABSTRACT  

Autologous 125I-Fibrinogen Uptake Test in the Detection and Management of Venous Thrombosis: A Prospective Study
Pollak et al.
Arch Surg 1974;109:48-51.
ABSTRACT  

Postoperative Thromboembolism: A Clinical Study With 125I-Fibrinogen and Pulmonary Scanning
Hartsuck and Greenfield
Arch Surg 1973;107:733-739.
ABSTRACT  

Open-Heart Surgery and the Demand for Blood
Roche and Stengle
JAMA 1973;225:1516-1521.
ABSTRACT  

Hepatitis-B Prevention and Gamma Globulin
KISLOFF
ANN INTERN MED 1973;78:151-153.
ABSTRACT  

Immune Serum Globulin for Protection Against Viral Hepatitis: Recommendation of the Public Health Service Advisory Committee on Immunization Practices
ANN INTERN MED 1972;77:427-430.
ABSTRACT